Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021.
2/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
410 patients, 5'928 (6.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Five-year net survival improved and reached a peak of 76.9% in 2010 for young men and 78.2% in 2007 for young women. [DISCUSSION] EOCRC incidence in Switzerland has risen continuously, with advanced stage at diagnosis and heterogeneous survival gains, underscoring the need for adapted prevention, awareness, and screening strategies.
OpenAlex 토픽 ·
Colorectal Cancer Screening and Detection
Genetic factors in colorectal cancer
Multiple and Secondary Primary Cancers
[INTRODUCTION] The incidence of colorectal cancer in adults younger than 50 years has increased, but the trends of incidence in Switzerland has not been yet described.
- 95% CI 0.17-0.76
APA
E. Fournier, Robin Schaffar, et al. (2026). Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021.. European journal of cancer (Oxford, England : 1990), 239, 116707. https://doi.org/10.1016/j.ejca.2026.116707
MLA
E. Fournier, et al.. "Rising early-onset colorectal cancer in Switzerland despite declining incidence in older adults: A nationwide population-based study, 1980-2021.." European journal of cancer (Oxford, England : 1990), vol. 239, 2026, pp. 116707.
PMID
41946179 ↗
Abstract 한글 요약
[INTRODUCTION] The incidence of colorectal cancer in adults younger than 50 years has increased, but the trends of incidence in Switzerland has not been yet described. We assessed long-term incidence, stage distribution, and survival of early-onset colorectal cancer (EOCRC) in Switzerland.
[MATERIALS AND METHODS] We conducted a nationwide, population-based study including all patients aged 20 years or older who were diagnosed with a first colorectal adenocarcinoma between 1980 and 2021, based on data from the National Cancer Dataset provided from the National Agency for Cancer Registration (NACR). Age-standardized incidence rates per 100'000 person-years were calculated using the 1976 European Standard Population. Temporal trends were assessed using joinpoint regression, expressed as annual percent change (APC). Stage distribution was analysed for 2010-21, when harmonized TNM data were available. Five-year net survival was estimated using the Pohar-Perme estimator.
[RESULTS] Among 96'410 patients, 5'928 (6.1%) were below 50 years old. Rectal cancers comprised 31.8% of EOCRC, versus 22.9% in those aged ≥ 75 years, whereas proximal colon cancers were less common (30.5% vs 42.7%, respectively). From 2010 to 2021, 27.7% of EOCRC were UICC stage IV, compared with 22.1% at ages 50-74 and 19.4% at ≥ 75. EOCRC incidence rose steadily (men: APC +0.46% [95% CI 0.17-0.76]; women: +0.49% [0.17-0.81]), driven by rectal cancers in both sexes and proximal colon cancers in young women. In contrast, incidence declined in older adults after the mid-2000s. Five-year net survival improved and reached a peak of 76.9% in 2010 for young men and 78.2% in 2007 for young women.
[DISCUSSION] EOCRC incidence in Switzerland has risen continuously, with advanced stage at diagnosis and heterogeneous survival gains, underscoring the need for adapted prevention, awareness, and screening strategies.
[MATERIALS AND METHODS] We conducted a nationwide, population-based study including all patients aged 20 years or older who were diagnosed with a first colorectal adenocarcinoma between 1980 and 2021, based on data from the National Cancer Dataset provided from the National Agency for Cancer Registration (NACR). Age-standardized incidence rates per 100'000 person-years were calculated using the 1976 European Standard Population. Temporal trends were assessed using joinpoint regression, expressed as annual percent change (APC). Stage distribution was analysed for 2010-21, when harmonized TNM data were available. Five-year net survival was estimated using the Pohar-Perme estimator.
[RESULTS] Among 96'410 patients, 5'928 (6.1%) were below 50 years old. Rectal cancers comprised 31.8% of EOCRC, versus 22.9% in those aged ≥ 75 years, whereas proximal colon cancers were less common (30.5% vs 42.7%, respectively). From 2010 to 2021, 27.7% of EOCRC were UICC stage IV, compared with 22.1% at ages 50-74 and 19.4% at ≥ 75. EOCRC incidence rose steadily (men: APC +0.46% [95% CI 0.17-0.76]; women: +0.49% [0.17-0.81]), driven by rectal cancers in both sexes and proximal colon cancers in young women. In contrast, incidence declined in older adults after the mid-2000s. Five-year net survival improved and reached a peak of 76.9% in 2010 for young men and 78.2% in 2007 for young women.
[DISCUSSION] EOCRC incidence in Switzerland has risen continuously, with advanced stage at diagnosis and heterogeneous survival gains, underscoring the need for adapted prevention, awareness, and screening strategies.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The Role of Vitamins and Micronutrients in the Prevention of Melanoma: A Review of Current Evidence.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Opposing prognostic roles of tumor-associated and circulating MMP8 in colorectal cancer.
- Copper-enriched zinc peroxides induced cuproptosis through concurrent metabolic and oxidative dysregulation for boosting immunotherapy in colorectal cancer.
- Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II.